Skip to main content

Generic Drugs Vs Medical fraternity Vs patients Vs Govt.

What is meant by generic drug? A generic drug is a copy of a brand name drug. To be sold, a generic drug must be “bioidentical” to the brand name drug. This means that the generic drug must be proven to be the same as the original brand name drug in the following ways: 
• dosage form (tablet, capsule, liquid, etc.)
• strength (same amount of drug in both)
• safety
• how it is taken (by mouth, injection, etc.)
• quality
• how the medicine gets into the bloodstream and works in the body .
Why generic drugs produced?
Because they are cheap and affordable to millions of patients.
What are the benefits of generic prescription, especially for our country?
Benefits are huge for patients suffering from prolonged illnesses such as cancer, HIV and diabetes. ''Most cancer drugs are costly. For example, Nexavar (a pioneer drug), used for treatment of liver and kidney cancer costs Rs 3 lakh per month for 120 tabs. The generic version costs Rs 7,000 per month. Another branded drug for lung cancer and head and neck cancer earlier cost Rs 80,000 per month for 100 tabs but with generic medicines available, it has come down to Rs 7,500. So, even original manufacturers are forced to reduce prices to remain competitive.
What is the recent policy shift of Indian govt.?
"India has put in place a $5.4 billion policy to provide free medicine to its people, 
a decision that could change the lives of hundreds of millions, but a ban 
on branded drugs stands to cut Big Pharma out of the windfall".
Why are Generic Drugs Cheaper Than Brand Name Drugs   ?
When a patent for a brand name drug expires, there are usually a number of companies that begin to make a generic version of the drug. Since there is more than one company making the drug, the price is lowered even farther due to competition between all of the different generic drug makers. 

Why majority of medical fraternity are apphrensive about usage of generic drugs?

There is no proper monitoring and quality control mechanism at retail and stockist level. even if the doctor prescribes generics, usually it has been supplemented by higher profitable branded drugs or another substandard generic drug.

The quality of generics of many players in India is very substandard.The manufacture is under Fertilisers & Chemicals Ministry , but the certification Process of the finished product is under the control of the MOH and DGCI..  

 

In the US, almost 80% prescriptions name generic drugs. 

In the UK, the generic prescription rate is 82%.

In india, Its only 30%. why?

Because, there is surety of quality and efficacy with branded drugs and having no confidence on generics , because the government's regulatory mechanism to check sale of spurious drugs in the name of generic drugs is simply not efficient, unlike in the US.The problem in India is compounded by hundreds of generic versions for one drug. "Regulators should allow limited branded generics of a particular compound and ensure quality".

Generic medicines have a few inherent disadvantages.
Several generic drugs were still not available in the market."Sunitinib, a medicine for kidney cancer, for instance, is not available in a generic form. 
More importantly, combination drugs can't be prescribed without a brand name. 
 A wider range of drugs is needed to effectively replace brands.
Big pharmaceuticals often sell both branded and generic medicines and the price difference is marginal. The idea is to maintain a monopoly, so the governement needs to be careful about this.
Retail medical shops could influence the ignorant consumers by promoting 
 a particular generic drug .

why this renewed direction from MCI?

Because,Now govt.wants to promote and sell generics country wide by establishing "generic drug stores-jana oushadhi". It’s just a reminder from MCI to our fraternity.

As per Section 1.5 code of medical ethics - 2002,  Every physician should, as far as possible, prescribe drugs with generic names and he / she shall ensure that there is a rational prescription and use of drugs.

What is the present status of generics in india?

India is one of the world's largest exporters of generic drugs. It exports to over 200 countries, including the highly regulated markets of US, Europe, Japan and Australia.
but,still the patients /consumers are not convinced and doubted the quality and they
don't want to take chances with their life.


A Person who runs the Jan Aushadhi store comments, that Generics we sell are 20% the price of branded drugs. Popular brands of paracetamol cost Rs 10 a strip of 10 tabs, whereas its non-branded, generic equivalent costs only Rs 2.45 per strip. Still, patients tend to go for the former."

How to deal with MNC company's strategy of “ever-greening of patent rights”?

India's top court to decide fate of India's cheap, generic drugs used by millions of poor

A ruling by India's Supreme Court is expected in early 2013.

Advise to doctors:
1.Complying with IMC regulations(regulation 1.5) & section 33(m) of the Indian Medical Council Act, 1956 (102 of 1956) & section 6 of the Consumer Protection Act, 1986,prescribe medicines by their chemical name and counsel the patients about drug's side effects and probable interaction with other medicines&food.
2.The doctors need not worry about  the quality of the medicine purchased by the patient from a pharmacy. No such responsibility lies upon the doctor. The responsibility for selling a spurious drug lies upon the seller.
3. when a doctor wants to dispense medicines to his / her own patients ,then the doctor has to bother about quality of the drugs  procured .
IMA-HBI AP's submission to MCI& MOH:
1. The Drug industry needs monitoring at all levels.
The Central Drugs Standard Control Organisation, the country's top drug regulatory 
body, is woefully understaffed — only 124 out of 327 sanctioned posts are filled. 
It also lacks sufficient lab facilities to check quality of medicines. 
Health ministry officials point out that while tests are conducted to check chemical composition of a generic drug, there are none to ensure 'bioequivalence' or its efficacy compared to the pioneer drug.
2. IMA HB definitely supports the greater common cause- "generic drug usage", if the govt gives assurance to the medical fraternity about the quality of said generics. 
IMA HBI observed, Out-of pocket spend accounts for 78% of health expenditure in India. Drugs alone account for 72% of what Indian families spend to stay healthy.
3. Union and state govts must Publish essential drug list and  initiate this generic revolution at all public hospitals and educate the masses by clearing their valid doubts regarding quality of generics. The govt should organize sensitization programs for doctors through 
IMA as ppm project.
4.Regulators should allow limited branded generics of a particular compound 
and ensure quality".
5. Govt.must take all stake holders especially IMAHBI ,in to confidence and chalk-out further action plan to popularise and implement the "quality generic" drug usage.

Comments